Back

Incidence and pattern of repeat coronary revascularizations in patients with acute coronary syndromes treated with ticagrelor or prasugrel

27 August 2023 (08:48 - 09:06)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in acute coronary syndromes Treatment ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Alp Aytekin

German Heart Center Muenchen Technical University of Munich, Munich (Germany)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
Professor G. Montalescot (Paris, FR)
Slides Video
Presentation thumbnail
SGLT-2 inhibitors are associated with lower rates of mortality following myocardial infarction in patients with type 2 diabetes - A SWEDEHEART observational study
Doctor H. Rosen (Lund, SE)
Abstract Slides Video
Presentation thumbnail
Current concepts of treatment for left ventricular thrombus: A sys-tematic meta-analysis comparing direct oral anticoagulants versus vitamin K-antagonists
Mr T. Seiler (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry
Mr A. Haakansson (Lund, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in acute coronary syndromes
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 08:48 CET
You may be interested in
thumbnail
Congress Presentation
Is prasugrel preferred over ticagrelor?
thumbnail
Congress Session
Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention
thumbnail
Congress Session
Novel pharmacological approaches in acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources